Advertisement

Topics

MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer

04:05 EDT 10 Sep 2017 | ecancermedicalscience

Dr Di Leo presents in a press conference at the ESMO 2017 Congress in Madrid data from the MONARCH 3 trail looking at abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer.  Dr Di Leo spoke with ecancer about the data...

Original Article: MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer

NEXT ARTICLE

More From BioPortfolio on "MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer"

Quick Search
Advertisement
 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...